Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Giant lung cysts following necrotizing pneumonia: Resolution with conservative treatment.

Gross I, Gordon O, Cohen-Cymberknoh M, Reiter J, Tsabari R, Gileles-Hillel A, Erlichman I, Hevroni A, Shoseyov D, Kerem E.

Pediatr Pulmonol. 2019 Jun;54(6):901-906. doi: 10.1002/ppul.24321. Epub 2019 Mar 21.

PMID:
30897292
2.

Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis.

Abu-Fraiha Y, Elyashar-Earon H, Shoseyov D, Cohen-Cymberknoh M, Armoni S, Kerem E, Wilschanski M.

J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):110-115. doi: 10.1097/MPG.0000000000002126.

PMID:
30095576
3.

[DIAGNOSIS AND TREATMENT OF BRONCHIECTASIS: POSITION PAPER OF THE ISRAELI PULMONOLOGY SOCIETY AND THE ISRAELI PEDIATRIC PULMONOLOGY SOCIETY].

Shteinberg M, Hardak E, Koslow M, Prais D, Cohen-Cymberkno M, Shoseyov D, Dagan A, Adir Y, Shitrit D.

Harefuah. 2018 Feb;157(2):117-121. Hebrew.

PMID:
29484869
4.

Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis.

Cohen-Cymberknoh M, Tanny T, Breuer O, Blau H, Mussaffi H, Kadosh D, Gartner S, Salinas A, Bentur L, Nir V, Gur M, Reiter J, Shoseyov D, Kerem E, Berger I.

J Cyst Fibros. 2018 Mar;17(2):281-285. doi: 10.1016/j.jcf.2017.11.020. Epub 2017 Dec 19.

PMID:
29269187
5.

Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.

Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, De Boeck K, Barbato A, Snijders D, Collura M, Pradal U, Blau H, Mussaffi H, Price M, Bentur L, Gur M, Aviram M, Picard E, Shteinberg M, Livnat G, Rivlin J, Hiller N, Shoseyov D, Amirav I, Kerem E.

Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.

PMID:
28947038
6.

Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia.

Breuer O, Picard E, Benabu N, Erlichman I, Reiter J, Tsabari R, Shoseyov D, Kerem E, Cohen-Cymberknoh M.

Chest. 2018 Jan;153(1):172-180. doi: 10.1016/j.chest.2017.09.021. Epub 2017 Sep 21.

PMID:
28943281
7.

Comparison of activity and fatigue of the respiratory muscles and pulmonary characteristics between post-polio patients and controls: A pilot study.

Shoseyov D, Cohen-Kaufman T, Schwartz I, Portnoy S.

PLoS One. 2017 Jul 27;12(7):e0182036. doi: 10.1371/journal.pone.0182036. eCollection 2017.

8.

Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Behar DM, Inbar O, Shteinberg M, Gur M, Mussaffi H, Shoseyov D, Ashkenazi M, Alkrinawi S, Bormans C, Hakim F, Mei-Zahav M, Cohen-Cymberknoh M, Dagan A, Prais D, Sarouk I, Stafler P, Bar Aluma BE, Akler G, Picard E, Aviram M, Efrati O, Livnat G, Rivlin J, Bentur L, Blau H, Kerem E, Singer A.

Mol Genet Genomic Med. 2017 Feb 19;5(3):223-236. doi: 10.1002/mgg3.278. eCollection 2017 May.

9.

Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.

Breuer O, Daum H, Cohen-Cymberknoh M, Unger S, Shoseyov D, Stepensky P, Keller B, Warnatz K, Kerem E.

Respir Med. 2017 May;126:39-45. doi: 10.1016/j.rmed.2017.03.018. Epub 2017 Mar 22.

10.

Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities.

Amirav I, Roduta Roberts M, Mussaffi H, Mandelberg A, Roth Y, Abitbul R, Luder A, Blau H, Alkrinawi S, Aviram M, Ben-Ami M, Rotschild M, Bentur L, Shoseyov D, Cohen-Cymberknoh M, Kerem E, Avital A, Springer C, Hevroni A, Dabbah H, Elizur A, Picard E, Goldberg S, Rivlin J, Livnat G, Lavie M, Alias N, Soferman R, Olbrich H, Raidt J, Wallmeier J, Werner C, Loges NT, Omran H.

Version 2. F1000Res. 2016 Aug 18 [revised 2016 Jan 1];5:2031. eCollection 2016.

11.

Comparison of Nasal Potential Difference and Intestinal Current Measurements as Surrogate Markers for CFTR Function.

Wilschanski M, Yaakov Y, Omari I, Zaman M, Martin CR, Cohen-Cymberknoh M, Shoseyov D, Kerem E, Dasilva D, Sheth S, Uluer A, OʼSullivan BP, Freedman S.

J Pediatr Gastroenterol Nutr. 2016 Nov;63(5):e92-e97.

PMID:
27496797
12.

Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices.

Abitbul R, Amirav I, Blau H, Alkrinawi S, Aviram M, Shoseyov D, Bentur L, Avital A, Springer C, Lavie M, Prais D, Dabbah H, Elias N, Elizur A, Goldberg S, Hevroni A, Kerem E, Luder A, Roth Y, Cohen-Cymberknoh M, Ben Ami M, Mandelberg A, Livnat G, Picard E, Rivlin J, Rotschild M, Soferman R, Loges NT, Olbrich H, Werner C, Wolter A, Herting M, Wallmeier J, Raidt J, Omran H, Mussaffi H.

Respir Med. 2016 Oct;119:41-47. doi: 10.1016/j.rmed.2016.08.015. Epub 2016 Aug 23.

13.

Complicated community acquired pneumonia in childhood: Different types, clinical course, and outcome.

Erlichman I, Breuer O, Shoseyov D, Cohen-Cymberknoh M, Koplewitz B, Averbuch D, Erlichman M, Picard E, Kerem E.

Pediatr Pulmonol. 2017 Feb;52(2):247-254. doi: 10.1002/ppul.23523. Epub 2016 Jul 8.

PMID:
27392317
14.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

15.

Treatment of cystic fibrosis in low-income countries.

Cohen-Cymberknoh M, Shoseyov D, Breuer O, Shamali M, Wilschanski M, Kerem E.

Lancet Respir Med. 2016 Feb;4(2):91-2. doi: 10.1016/S2213-2600(15)00507-X. No abstract available.

PMID:
26868623
16.

Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease.

Breuer O, Shteyer E, Wilschanski M, Perles Z, Cohen-Cymberknoh M, Kerem E, Shoseyov D.

Chest. 2016 Feb;149(2):e35-e38. doi: 10.1016/j.chest.2015.10.040.

17.

Ataluren for the treatment of cystic fibrosis.

Shoseyov D, Cohen-Cymberknoh M, Wilschanski M.

Expert Rev Respir Med. 2016 Apr;10(4):387-391. doi: 10.1586/17476348.2016.1150181. Epub 2016 Feb 24.

PMID:
26840186
18.

Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis.

Pugatsch T, Shoseyov D, Cohen-Cymberknoh M, Hayut B, Armoni S, Griese M, Kerem E.

Pediatr Pulmonol. 2016 Feb;51(2):143-6. doi: 10.1002/ppul.23344. Epub 2015 Nov 19.

PMID:
26583331
19.

The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening.

Stafler P, Mei-Zahav M, Wilschanski M, Mussaffi H, Efrati O, Lavie M, Shoseyov D, Cohen-Cymberknoh M, Gur M, Bentur L, Livnat G, Aviram M, Alkrinawi S, Picard E, Prais D, Steuer G, Inbar O, Kerem E, Blau H.

J Cyst Fibros. 2016 Jul;15(4):460-6. doi: 10.1016/j.jcf.2015.08.007. Epub 2015 Sep 16.

20.

Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis.

Gileles-Hillel A, Shoseyov D, Polacheck I, Korem M, Kerem E, Cohen-Cymberknoh M.

Pediatr Pulmonol. 2015 Nov;50(11):1082-9. doi: 10.1002/ppul.23302. Epub 2015 Sep 18.

PMID:
26383963
21.

Implementation of a Policy Change: Replacement of Nebulizers by Spacers for the Treatment of Asthma in Children.

Breuer O, Shoseyov D, Kerem E, Brooks R.

Isr Med Assoc J. 2015 Jul;17(7):421-4.

22.

Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice.

Rosen C, Shezen E, Aronovich A, Klionsky YZ, Yaakov Y, Assayag M, Biton IE, Tal O, Shakhar G, Ben-Hur H, Shneider D, Vaknin Z, Sadan O, Evron S, Freud E, Shoseyov D, Wilschanski M, Berkman N, Fibbe WE, Hagin D, Hillel-Karniel C, Krentsis IM, Bachar-Lustig E, Reisner Y.

Nat Med. 2015 Aug;21(8):869-79. doi: 10.1038/nm.3889. Epub 2015 Jul 13.

PMID:
26168294
23.

Systemic steroid treatment for severe expanding pneumococcal pneumonia.

Lavi E, Shoseyov D, Simanovsky N, Brooks R.

Case Rep Pediatr. 2015;2015:186302. doi: 10.1155/2015/186302. Epub 2015 Feb 26.

24.

Immunofluorescence Analysis and Diagnosis of Primary Ciliary Dyskinesia with Radial Spoke Defects.

Frommer A, Hjeij R, Loges NT, Edelbusch C, Jahnke C, Raidt J, Werner C, Wallmeier J, Große-Onnebrink J, Olbrich H, Cindrić S, Jaspers M, Boon M, Memari Y, Durbin R, Kolb-Kokocinski A, Sauer S, Marthin JK, Nielsen KG, Amirav I, Elias N, Kerem E, Shoseyov D, Haeffner K, Omran H.

Am J Respir Cell Mol Biol. 2015 Oct;53(4):563-73. doi: 10.1165/rcmb.2014-0483OC.

25.

Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.

Breuer O, Blich O, Cohen-Cymberknoh M, Averbuch D, Kharasch S, Shoseyov D, Kerem E.

Pediatr Pulmonol. 2015 May;50(5):495-502. doi: 10.1002/ppul.23159. Epub 2015 Feb 4.

PMID:
25652187
26.

Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O.

World J Gastroenterol. 2015 Jan 7;21(1):318-25. doi: 10.3748/wjg.v21.i1.318.

27.

Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity.

Breuer O, Cohen-Cymberknoh M, Armoni S, Kerem E, Shoseyov D.

Ann Allergy Asthma Immunol. 2014 Aug;113(2):229-30. doi: 10.1016/j.anai.2014.05.014. Epub 2014 Jun 13. No abstract available.

PMID:
24934107
28.

Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel.

Peled O, Kalamaro V, Kerem E, Shoseyov D, Blau H, Efrati O, Block C.

J Cyst Fibros. 2014 Sep;13(5):550-6. doi: 10.1016/j.jcf.2014.01.001. Epub 2014 Jan 28.

29.

Phospholipase A2 in experimental allergic bronchitis: a lesson from mouse and rat models.

Mruwat R, Yedgar S, Lavon I, Ariel A, Krimsky M, Shoseyov D.

PLoS One. 2013 Oct 29;8(10):e76641. doi: 10.1371/journal.pone.0076641. eCollection 2013.

30.

Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency.

Cohen-Cymberknoh M, Simanovsky N, Hiller N, Hillel AG, Shoseyov D, Kerem E.

Chest. 2014 Apr;145(4):738-744. doi: 10.1378/chest.13-1162.

PMID:
24091606
31.

CCDC65 mutation causes primary ciliary dyskinesia with normal ultrastructure and hyperkinetic cilia.

Horani A, Brody SL, Ferkol TW, Shoseyov D, Wasserman MG, Ta-shma A, Wilson KS, Bayly PV, Amirav I, Cohen-Cymberknoh M, Dutcher SK, Elpeleg O, Kerem E.

PLoS One. 2013 Aug 26;8(8):e72299. doi: 10.1371/journal.pone.0072299. eCollection 2013.

32.

[How can asthma in children be controlled?].

Rousso S, Shoseyov D, Kerem E.

Harefuah. 2013 May;152(5):299-303, 307. Review. Hebrew.

PMID:
23885456
33.

NKp46 regulates allergic responses.

Ghadially H, Horani A, Glasner A, Elboim M, Gazit R, Shoseyov D, Mandelboim O.

Eur J Immunol. 2013 Nov;43(11):3006-16. doi: 10.1002/eji.201343388. Epub 2013 Aug 21.

34.

Mitochondrial OXPHOS function is unaffected by chronic azithromycin treatment.

Negari SB, Aouizerat T, Tenenbaum A, Cohen-Cymberknoh M, Shoseyov D, Kerem E, Saada A.

J Cyst Fibros. 2013 Dec;12(6):682-7. doi: 10.1016/j.jcf.2013.04.006. Epub 2013 May 13.

35.

LRRC6 mutation causes primary ciliary dyskinesia with dynein arm defects.

Horani A, Ferkol TW, Shoseyov D, Wasserman MG, Oren YS, Kerem B, Amirav I, Cohen-Cymberknoh M, Dutcher SK, Brody SL, Elpeleg O, Kerem E.

PLoS One. 2013;8(3):e59436. doi: 10.1371/journal.pone.0059436. Epub 2013 Mar 19.

36.

Differences in the pattern of structural abnormalities on CT scan in patients with cystic fibrosis and pancreatic sufficiency or insufficiency.

Simanovsky N, Cohen-Cymberknoh M, Shoseyov D, Gileles-Hillel A, Wilschanski M, Kerem E, Hiller N.

Chest. 2013 Jul;144(1):208-214. doi: 10.1378/chest.12-1226.

PMID:
23392565
37.

Triphala (PADMA) extract alleviates bronchial hyperreactivity in a mouse model through liver and spleen immune modulation and increased anti-oxidative effects.

Horani A, Shoseyov D, Ginsburg I, Mruwat R, Doron S, Amer J, Safadi R.

Ther Adv Respir Dis. 2012 Aug;6(4):199-210. doi: 10.1177/1753465812452194. Epub 2012 Jul 4.

PMID:
22763675
38.

Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis.

Cohen-Cymberknoh M, Yaakov Y, Shoseyov D, Shteyer E, Schachar E, Rivlin J, Bentur L, Picard E, Aviram M, Israeli E, Kerem E, Wilschanski M.

Pediatr Pulmonol. 2013 Mar;48(3):229-35. doi: 10.1002/ppul.22586. Epub 2012 May 2.

PMID:
22553157
39.

Laryngeal obstruction in congenital plasminogen deficiency.

Cohen J, Cohen S, Cymberknoh MC, Gross M, Hirshoren N, Shoseyov D.

Pediatr Pulmonol. 2012 Sep;47(9):923-5. doi: 10.1002/ppul.22522. Epub 2012 Feb 10. Review.

PMID:
22328462
40.

Tumor suppressor death-associated protein kinase attenuates inflammatory responses in the lung.

Nakav S, Cohen S, Feigelson SW, Bialik S, Shoseyov D, Kimchi A, Alon R.

Am J Respir Cell Mol Biol. 2012 Mar;46(3):313-22. doi: 10.1165/rcmb.2011-0181OC. Epub 2011 Oct 13.

PMID:
21997486
41.

Could you please pass the salt?

Shoseyov D, Cohen-Cymberknoh M, Kerem E.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1444-6. doi: 10.1164/rccm.201102-0351ED. No abstract available.

PMID:
21642252
42.

Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis.

Kerem E, Wilschanski M, Miller NL, Pugatsch T, Cohen T, Blau H, Rivlin J, Shoseyov D, Reha A, Constantine S, Ajayi T, Hirawat S, Elfring GL, Peltz SW, Miller LL.

J Cyst Fibros. 2011 May;10(3):193-200. doi: 10.1016/j.jcf.2011.02.003. Epub 2011 Apr 2.

43.

Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.

Cohen-Cymberknoh M, Shoseyov D, Kerem E.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1463-71. doi: 10.1164/rccm.201009-1478CI. Epub 2011 Feb 17. Review.

PMID:
21330455
44.

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.

Wilschanski M, Miller LL, Shoseyov D, Blau H, Rivlin J, Aviram M, Cohen M, Armoni S, Yaakov Y, Pugatsch T, Cohen-Cymberknoh M, Miller NL, Reha A, Northcutt VJ, Hirawat S, Donnelly K, Elfring GL, Ajayi T, Kerem E.

Eur Respir J. 2011 Jul;38(1):59-69. doi: 10.1183/09031936.00120910. Epub 2011 Jan 13. Erratum in: Eur Respir J. 2011 Oct;38(4):996. Pugatch, T [corrected to Pugatsch, T].

45.

Oxidized cellulose binding to allergens with a carbohydrate-binding module attenuates allergic reactions.

Shani N, Shani Z, Shoseyov O, Mruwat R, Shoseyov D.

J Immunol. 2011 Jan 15;186(2):1240-7. doi: 10.4049/jimmunol.1000640. Epub 2010 Dec 17.

46.

Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liver.

Horani A, Shoseyov D, Doron S, Mruwat R, Amer J, Kerem E, Safadi R.

Immunobiology. 2011 May;216(5):548-57. doi: 10.1016/j.imbio.2010.10.002. Epub 2010 Oct 20.

PMID:
21074892
47.

Late-onset central hypoventilation presenting as extubation failure.

Cohen-Cymberknoh M, Shoseyov D, Goldberg S, Gross E, Amiel J, Kerem E.

Isr Med Assoc J. 2010 Apr;12(4):249-50. No abstract available.

48.

Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation.

Sc NN, Shoseyov D, Kerem E, Zangen DH.

J Cyst Fibros. 2010 May;9(3):199-204. doi: 10.1016/j.jcf.2010.02.001. Epub 2010 Feb 25.

49.

18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis.

Klein M, Cohen-Cymberknoh M, Armoni S, Shoseyov D, Chisin R, Orevi M, Freedman N, Kerem E.

Chest. 2009 Nov;136(5):1220-1228. doi: 10.1378/chest.09-0610. Epub 2009 Aug 20.

PMID:
19696124
50.

Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study.

Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J.

J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):173-8. doi: 10.1097/MPG.0b013e3181a3bfdd.

PMID:
19668004

Supplemental Content

Loading ...
Support Center